Replies to post #110743 on Amarin Corp Plc (AMRN)

[dockside130]

Bad science
The statin article was published in The Annals of Internal Medicine. This is a reputable journal. I do not see where this is supported by pharma. I believe in Vascepa however statins do save lives.
I am sure the combined Vascepa-statin therapy will be even more of a life saver.
I presently prescribe statins daily.

[Whalatane]

JL the data are the data

Paul Ridker on criticism's of the Jupiter Trial and his part in it .

"On the conflict-of-interest issue, he said: "People are well aware of my conflict regarding the patent for the CRP test. It has been written about publicly. But the data are the data.
If we were trying to maximize the value of the patent, we would never have done this study, as we wouldn't have risked it not showing benefit.
The patent is owned by my hospital, not by me, and they fully comply with extremely rigorous rules.
Yes, I do get some financial benefit from it, but when talking about conflict you have to look at the data. And our data are good.
This is one of the most independent trials ever done. We had a truly independent DSMB, totally independent statisticians, and we structured this trial to be completely independent of the company. They're going after Rory Collins here, and he is one of the most highly respected independent clinical trialists there is."

So ...since AMRN is funding R-IT ...can we trust the results ?
Apparently in your view of industry funded clinical trials..., maybe not .

Kiwi